IRIS
RUSSO, PAOLA ROSA NICE MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 593
EU - Europa 457
AS - Asia 311
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 592
CN - Cina 289
IE - Irlanda 160
FI - Finlandia 96
UA - Ucraina 69
DE - Germania 61
IT - Italia 24
SG - Singapore 18
SE - Svezia 12
BE - Belgio 10
GB - Regno Unito 10
FR - Francia 8
NL - Olanda 2
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
IN - India 1
JP - Giappone 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.364
Salva come PNG Salva come JPEG
Città #
Dublin 160
Chandler 144
Jacksonville 98
Nanjing 97
Helsinki 46
Ann Arbor 43
Ashburn 37
Nanchang 36
Boardman 35
Beijing 34
Princeton 26
Shenyang 26
Lawrence 24
Wilmington 24
Changsha 23
Medford 22
Jiaxing 17
Hebei 15
Hangzhou 13
Singapore 12
Woodbridge 11
Brussels 10
Tianjin 10
Milan 7
Norwalk 7
Shanghai 6
Verona 5
Pavia 4
Des Moines 3
Bari 2
Berlin 2
Dallas 2
Latisana 2
Los Angeles 2
New York 2
Redwood City 2
Seattle 2
Brisbane 1
Brno 1
Changchun 1
Fairfield 1
Falkenstein 1
Gazipur 1
Kunming 1
Lower Hutt 1
Lugano 1
Ningbo 1
Piscataway 1
Pune 1
Richmond 1
Rockville 1
Taizhou 1
Tokyo 1
Zhengzhou 1
Totale 1.028
Salva come PNG Salva come JPEG
Nome #
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. 84
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 77
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 77
Reasoning with Effects of Clinical Guideline Actions Using OWL: AL Amyloidosis as a Case StudyKnowledge Representation for Health-Care 73
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine 68
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 68
Correlation between serum concentrations of N-terminal natriuretic peptide type B (NT-proBNP) and troponin-I (TnI) in AL amyloidosis 66
G-quest: a single platform for delivering questionnaires, educational material, and checklists on mobile devices 61
AMICA: an electronic patient record specifically designed for an amyloidosis network. 59
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 58
Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis 57
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 56
Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib and dexamethasone 55
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib and thalidomide 55
Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study. 55
Delivering and assessing learning material through Gquest: A case study on patient education 54
AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical Entity 51
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis 50
A workflow management system for the biological samples exchange within the amyloidosis network 45
Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients 44
A system for the extraction and representation of summary of product characteristics content. 42
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. 39
Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits 38
The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients 36
The workings of the amyloid diseases. 25
Totale 1.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 15 2 15 2 15 3 46 6 0
2020/2021137 17 13 3 15 1 17 3 26 3 22 16 1
2021/2022108 4 4 0 4 3 0 2 12 5 5 16 53
2022/2023435 60 47 4 25 41 41 3 19 180 1 9 5
2023/2024141 26 40 4 5 15 26 1 12 3 4 1 4
2024/202542 14 28 0 0 0 0 0 0 0 0 0 0
Totale 1.393